Aluminum Hydroxide and Magnesium Trisilicate and Risankizumab-rzaa topical
Determining the interaction of Aluminum Hydroxide and Magnesium Trisilicate and Risankizumab-rzaa topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aluminum hydroxide / magnesium trisilicate
Brand name: Drysol, Hypercare, Xerac AC, Gaviscon Tablet
Synonyms: n.a.
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Risankizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aluminum Hydroxide and Magnesium Trisilicate-Risedronate
- Aluminum Hydroxide and Magnesium Trisilicate-Risedronate and Calcium
- Aluminum Hydroxide and Magnesium Trisilicate-Risedronate Delayed Release
- Aluminum Hydroxide and Magnesium Trisilicate-Risedronate Delayed-Release Tablets
- Aluminum Hydroxide and Magnesium Trisilicate-Risedronate Sodium
- Aluminum Hydroxide and Magnesium Trisilicate-Risedronate Tablets
- Risankizumab-rzaa topical-Aluminum hydroxide, magnesium hydroxide, and simethicone
- Risankizumab-rzaa topical-Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone Chewable Tablets
- Risankizumab-rzaa topical-Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone Suspension
- Risankizumab-rzaa topical-Alunbrig
- Risankizumab-rzaa topical-Alupent
- Risankizumab-rzaa topical-Alupent (Metaproterenol Syrup)